These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30193808)

  • 1. Disrupting interaction of PSD-95 with nNOS attenuates hemorrhage-induced thalamic pain.
    Cai W; Wu S; Pan Z; Xiao J; Li F; Cao J; Zang W; Tao YX
    Neuropharmacology; 2018 Oct; 141():238-248. PubMed ID: 30193808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA
    Li J; Zhang L; Xu C; Shen YY; Lin YH; Zhang Y; Wu HY; Chang L; Zhang YD; Chen R; Zhang ZP; Luo CX; Li F; Zhu DY
    Theranostics; 2021; 11(12):5970-5985. PubMed ID: 33897893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of nNOS from PSD-95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes.
    Lin YH; Liang HY; Xu K; Ni HY; Dong J; Xiao H; Chang L; Wu HY; Li F; Zhu DY; Luo CX
    J Pathol; 2018 Feb; 244(2):176-188. PubMed ID: 29053192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.
    Lee WH; Xu Z; Ashpole NM; Hudmon A; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
    Neuropharmacology; 2015 Oct; 97():464-75. PubMed ID: 26071110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD.
    Li LP; Dustrude ET; Haulcomb MM; Abreu AR; Fitz SD; Johnson PL; Thakur GA; Molosh AI; Lai Y; Shekhar A
    Transl Psychiatry; 2018 Aug; 8(1):155. PubMed ID: 30108200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO (Fat-Mass and Obesity-Associated Protein) Participates in Hemorrhage-Induced Thalamic Pain by Stabilizing Toll-Like Receptor 4 Expression in Thalamic Neurons.
    Fu G; Du S; Huang T; Cao M; Feng X; Wu S; Albik S; Bekker A; Tao YX
    Stroke; 2021 Jul; 52(7):2393-2403. PubMed ID: 34102854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury.
    Qu W; Liu NK; Wu X; Wang Y; Xia Y; Sun Y; Lai Y; Li R; Shekhar A; Xu XM
    Cereb Cortex; 2020 Jun; 30(7):3859-3871. PubMed ID: 31989159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling nNOS-PSD-95 in mPFC inhibits morphine priming-induced reinstatement after extinction training.
    Kou XL; Tao Y; Xian JY; Lin YH; Cai CY; Wu HY; Chang L; Zhu DY
    Biochem Biophys Res Commun; 2020 Apr; 525(2):520-527. PubMed ID: 32113678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.
    Carey LM; Lee WH; Gutierrez T; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
    Neuroscience; 2017 May; 349():303-317. PubMed ID: 28285942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.
    Sun Z; Meng P; Su C; Ji S; Gao Y; Wang H; Tian J; Li C
    Toxicol Appl Pharmacol; 2021 Oct; 429():115698. PubMed ID: 34428447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fgr contributes to hemorrhage-induced thalamic pain by activating NF-κB/ERK1/2 pathways.
    Huang T; Fu G; Gao J; Zhang Y; Cai W; Wu S; Jia S; Xia S; Bachmann T; Bekker A; Tao YX
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.
    Sherwin E; Lennon A; Harkin A
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):833-843. PubMed ID: 28977524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting PSD95/nNOS by ZL006 alleviates social isolation-induced heightened attack behavior in mice.
    Yang L; Cui J; Zeng L; Lu W
    Psychopharmacology (Berl); 2022 Jan; 239(1):267-276. PubMed ID: 34661719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
    Zhou L; Li F; Xu HB; Luo CX; Wu HY; Zhu MM; Lu W; Ji X; Zhou QG; Zhu DY
    Nat Med; 2010 Dec; 16(12):1439-43. PubMed ID: 21102461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZL006 protects spinal cord neurons against ischemia-induced oxidative stress through AMPK-PGC-1α-Sirt3 pathway.
    Liu SG; Wang YM; Zhang YJ; He XJ; Ma T; Song W; Zhang YM
    Neurochem Int; 2017 Sep; 108():230-237. PubMed ID: 28411102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSD-95-nNOS Coupling Regulates Contextual Fear Extinction in the Dorsal CA3.
    Cai CY; Chen C; Zhou Y; Han Z; Qin C; Cao B; Tao Y; Bian XL; Lin YH; Chang L; Wu HY; Luo CX; Zhu DY
    Sci Rep; 2018 Aug; 8(1):12775. PubMed ID: 30143658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.
    Bach A; Pedersen SW; Dorr LA; Vallon G; Ripoche I; Ducki S; Lian LY
    Sci Rep; 2015 Jul; 5():12157. PubMed ID: 26177569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABA
    Wei W; Liu W; Du S; Govindarajalu G; Irungu A; Bekker A; Tao YX
    Neurotherapeutics; 2021 Oct; 18(4):2436-2448. PubMed ID: 34796458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.
    Florio SK; Loh C; Huang SM; Iwamaye AE; Kitto KF; Fowler KW; Treiberg JA; Hayflick JS; Walker JM; Fairbanks CA; Lai Y
    Br J Pharmacol; 2009 Sep; 158(2):494-506. PubMed ID: 19732061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
    Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
    Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.